Long-acting recombinant follicle-stimulating hormone in random-start ovarian stimulation protocols for fertility preservation in women with cancer.
Veronica SaraisAlessio PaffoniLuca PagliardiniFrancesca FilippiFabio MartinelliGiorgia MangiliMassimo CandianiEnrico PapaleoPublished in: Acta obstetricia et gynecologica Scandinavica (2017)
The use of long-acting recombinant FSH in random-start protocols for fertility preservation appears to be a valuable option.